Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:40:03.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    No additions or deletions to core study information were observed; the page content remains unchanged aside from minor UI/metadata adjustments.
    Difference
    0.1%
    Check dated 2026-02-27T18:51:03.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Fallopian tube cancer term added and a link to the Genetic and Rare Diseases Information Center added under resources. Page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T12:47:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a revision update from v3.4.0 to v3.4.1, which is a minor change that does not modify the study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:18:00.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The changes are minor UI and versioning updates: addition of Show glossary and Hide glossary options, and label wording updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data) plus the revision tag to v3.4.0. These updates do not modify the study content or how the page functions.
    Difference
    0.4%
    Check dated 2026-01-22T17:43:51.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed, which are metadata updates that do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:55:42.000Z thumbnail image

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.